Previous close | 10.00 |
Open | 10.01 |
Bid | 10.03 x 45900 |
Ask | 10.18 x 900 |
Day's range | 10.00 - 10.11 |
52-week range | 9.98 - 10.65 |
Volume | 347,214 |
Avg. volume | 302,473 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
SCP & CO Healthcare Acquisition Company (the "Company") (NASDAQ: SHACU), announced the closing of its upsized initial public offering of 23,000,000 units at $10.00 per unit, including 3,000,000 units pursuant to the full exercise of the underwriters' over-allotment option. The offering was priced at $10.00 per unit, resulting in gross proceeds of $230,000,000.
SCP & CO Healthcare Acquisition Company (the "Company"), announced today the pricing of its upsized initial public offering of 20,000,000 units at a price of $10.00 per unit. The units are expected to begin trading on the Nasdaq Capital Market ("Nasdaq") on January 22, 2021 under the symbol "SHACU". Each unit consists of one share of Class A common stock and one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share. Only whole warrants are exercisable. Once the securities comprising the units begin separate trading, the Class A common stock and warrants are expected to be listed on Nasdaq under the symbols "SHAC" and "SHACW", respectively.